Role of enteroviruses in the pathogenesis of type 1 diabetes M. RoivainenK. Klingel Commentary 26 March 2009 Pages: 995 - 996
The co-evolution of our understanding of CD40 and inflammation D. H. Wagner Jr Commentary 10 April 2009 Pages: 997 - 999
Inherited susceptibility to non-alcoholic fatty liver disease R. J. F. LoosD. B. Savage Commentary 25 March 2009 Pages: 1000 - 1002
The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality S. E. KahnS. ZraikaR. L. Hull Review 27 March 2009 Pages: 1003 - 1012
Technophobia, prescription checking and the future of diabetes management A. M. Albisser For Debate 09 April 2009 Pages: 1013 - 1018
Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2) A. RamachandranC. SnehalathaA. S. Shetty Article 10 March 2009 Pages: 1019 - 1026
The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2 C. ChielliniF. RubinoG. Mingrone Short Communication 24 March 2009 Pages: 1027 - 1030
Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study W. L. XuE. von StraussL. Fratiglioni Article 12 March 2009 Pages: 1031 - 1039
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis C. C. LeeA. I. AdlerN. J. Wareham Article 27 March 2009 Pages: 1040 - 1047
Bivariate genetic modelling of the response to an oral glucose tolerance challenge: A gene × environment interaction approach G. F. LiuH. RieseH. Snieder Article 14 March 2009 Pages: 1048 - 1055
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans A. KotronenL. E. JohanssonH. Yki-Järvinen Short Communication 18 February 2009 Pages: 1056 - 1060
Agreement among type 2 diabetes linkage studies but a poor correlation with results from genome-wide association studies S. LilliojaA. Wilton Article 19 March 2009 Pages: 1061 - 1074
A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion S. A. SchäferK. MüssigA. Fritsche Article 28 March 2009 Pages: 1075 - 1082
Autophagy in human type 2 diabetes pancreatic beta cells M. MasiniM. BuglianiP. Marchetti Brief Communication 15 April 2009 Pages: 1083 - 1086
Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes M. J. MacDonaldM. J. LongacreC.-G. Ostenson Short Communication 19 March 2009 Pages: 1087 - 1091
Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-κB) signalling in human islets and in a mouse beta cell line S. A. SarkarB. KutluS. Pugazhenthi Article 03 April 2009 Pages: 1092 - 1101
Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress R. L. HullS. ZraikaS. E. Kahn Article 08 April 2009 Pages: 1102 - 1111
Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the KATP channel and insulin secretion in rats T.-J. ChangW.-P. ChenL.-M. Chuang Article 09 April 2009 Pages: 1112 - 1121
Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass V. Delghingaro-AugustoC. J. NolanJ. Leahy Article 18 March 2009 Pages: 1122 - 1132
Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance P. NivoitC. MorensB. Reusens Article 14 March 2009 Pages: 1133 - 1142
The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes S. J. RichardsonA. WillcoxN. G. Morgan Article 06 March 2009 Pages: 1143 - 1151
The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes M. PoggiJ. JagerM. C. Alessi Article 31 January 2009 Pages: 1152 - 1163
Early autonomic dysfunction in type 1 diabetes: a reversible disorder? M. Rosengård-BärlundL. BernardiFinnDiane Study Group Article 02 April 2009 Pages: 1164 - 1172
Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes M. L. MarcovecchioR. N. DaltonD. B. Dunger Article 21 March 2009 Pages: 1173 - 1181
Accelerated atrophy of lower leg and foot muscles—a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI) C. S. AndreassenJ. JakobsenH. Andersen Article 12 March 2009 Pages: 1182 - 1191
Blocking AMPA receptor signalling by caroverine infusion does not affect counter-regulation of hypoglycaemia in healthy men J. KlementI. PaisA. Peters Short Communication 03 April 2009 Pages: 1192 - 1196
Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFκB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance M. P. SajanM. L. StandaertR. V. Farese Article 09 April 2009 Pages: 1197 - 1207
IRS2 variants and syndromes of severe insulin resistance W. E. BottomleyM. A. SoosI. Barroso Research Letter Open access 18 April 2009 Pages: 1208 - 1211
Thiamine in diabetic nephropathy: a novel treatment modality? A. AlkhalafN. KleefstraH. J. G. Bilo Letter Open access 19 March 2009 Pages: 1212 - 1213
Thiamine in diabetic nephropathy: a novel treatment modality? Reply to Alkhalaf A, Kleefstra N, Groenier KH et al. [letter] N. RabbaniS. S. AlamP. J. Thornalley Letter 25 March 2009 Pages: 1214 - 1216
Optimal dosing of renin–angiotensin–aldosterone system blockers for renal protection: a solved issue? G. D. LavermanS. J. L. BakkerG. J. Navis Letter Open access 18 March 2009 Pages: 1217 - 1218
